SOAT1 and rheumatoid arthritis: The multicellular effects of HDAC6 inhibition by CKD-506 might contribute to the anti-arthritic effects observed in the murine RA model; these effects were comparable with those of tofacitinib, a JAK/STAT signaling inhibitor with proven clinical efficacy (Fig. 4).